Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
10 min read
Allergic fungal rhinosinusitis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Allergic fungal rhinosinusitis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Chronic rhinosinusitis without nasal polyps Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Chronic rhinosinusitis without nasal polyps strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with.
Latest Hotspot
10 min read
Excessive dynamic airway collapse Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Excessive dynamic airway collapse strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP.
Latest Hotspot
10 min read
Subglottic stenosis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Subglottic stenosis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Recurrent respiratory papillomatosis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Recurrent respiratory papillomatosis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap.
Latest Hotspot
10 min read
Vocal cord paralysis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Vocal cord paralysis strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
Spasmodic dysphonia Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Spasmodic dysphonia indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Vocal fold scarring Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Vocal fold scarring indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Hyperacusis Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Hyperacusis indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Pulsatile tinnitus Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
Explore the 2026 Pulsatile tinnitus indication strategy: epidemiology, unmet need, target biology, clinical competition and deal signals using PatSnap MCP evidence.
Latest Hotspot
10 min read
Cochlear synaptopathy Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 Cochlear synaptopathy strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.
Latest Hotspot
10 min read
GJB2-related hearing loss Indication Strategy Report 2026: Epidemiology, Targets, Trials and Deals
4 August 2026
2026 GJB2-related hearing loss strategy covering epidemiology, unmet need, target biology, clinical competition and deal signals, built with PatSnap MCP evidence.